Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03444883 |
| Consolidated Lead Sponsor | Il-Yang Pharm. Co |
| Therapeutic Condition Cohort | Gastroenterology, Hepatology, and Renal |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 277 participants (ACTUAL) |
| Registered Start Date | 2018-10-31 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Seoul National University Bundang Hospital | Seongnam-si, South Korea | Open Hospital Dossier -> |
| Seoul National University Hospital | Seoul, South Korea | Open Hospital Dossier -> |
| Severance Hospital, Yonsei University Health System | Seoul, South Korea | Open Hospital Dossier -> |
| Asan Medical Center | Seoul, South Korea | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.